DOI: https://doi.org/10.22141/2224-0721.14.6.2018.146071

Approaches to the correction of indexes of blood lipids and liver functional state in patients with hypothalamic dysfunction

V.I. Pankiv

Abstract


The lecture presents a modern view on etiology, pathogenesis and correction of hypothalamic dysfunction, describes the correlation between hypothalamic dysfunction and liver functio­nal state. The comprehensive method of treatment of these patients is described, with application of ursodeoxycholic acid. Author’s experience of Ursofalk use allows recommending the preparation at a dose of 15 mg/kg body weight daily in three divided doses, for three months, in patients with hypothalamic dysfunction.

Keywords


hypothalamic dysfunction; liver functional state; ursodeoxycholic acid

References


Williams LM. Hypothalamic dysfunction in obesity. Proc Nutr Soc. 2012;71(4):521-33. doi: 10.1017/S002966511200078X.

de Git KC, Adan RA. Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation. Obes Rev. 2015 Mar;16(3):207-24. doi: 10.1111/obr.12243.

Smith JK. Exercise, obesity and CNS control of metabolic homeostasis: a review. Front Physiol. 2018 May 17;9:574. doi: 10.3389/fphys.2018.00574.

Uvarova EV, Khashchenko EP. Hypothalamic dysfunction: etiology and pathogenesis (review). Reproduktivnoe zdorovʹe detej i podrostkov. 2010;(1):35-47. (in Russian).

Pylypenko VM. A role of gamma-Aminobutyric acid in pathogenesis of hypothalamic dysfunction. Methods of correction and prevention of neuromediator violations. Zdorovya Ukrayiny. 2017;1(37):44-47. (in Ukrainian).

Batterham RL, Ffytche DH, Rosenthal JM, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature. 2007 Nov 1;450(7166):106-9. doi: 10.1038/nature06212.

D’Agostino G, Lyons DJ, Cristiano C, et al. Appetite controlled by a cholecystokinin nucleus of the solitary tract to hypothalamus neurocircuit. Elife. 2016 Mar 14;5. pii: e12225. doi: 10.7554/eLife.12225.

Dietrich MO, Horvath TL. Hypothalamic control of energy balance: insights into the role of synaptic plasticity. Trends Neurosci. 2013 Feb;36(2):65-73. doi: 10.1016/j.tins.2012.12.005.

Garfield AS, Shah BP, Madara JC, et al. A parabrachial-hypothalamic cholecystokinin neurocircuit controls counterregulatory responses to hypoglycemia. Cell Metab. 2014 Dec 2;20(6):1030-7. doi: 10.1016/j.cmet.2014.11.006.

Shah BP, Vong L, Olson DP, Koda S, et al. MC4R-expressing glutamatergic neurons in the paraventricular hypothalamus regulate feeding and are synaptically connected to the parabrachial nucleus. Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13193-8. doi: 10.1073/pnas.1407843111.

Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016 Jul;22 Suppl 3:1-203. doi: 10.4158/EP161365.GL.

Furlong TM, McDowall LM, Horiuchi J, Polson JW, Dampney RA. The effect of air puff stress on c-Fos expression in rat hypothalamus and brainstem: central circuitry mediating sympathoexcitation and baroreflex resetting. Eur J Neurosci. 2014 May;39(9):1429-38. doi: 10.1111/ejn.12521.

Li AJ, Dinh TT, Ritter S. Hyperphagia and obesity produced by arcuate injection of NPY-saporin do not require upregulation of lateral hypothalamic orexigenic peptide genes. Peptides. 2008 Oct;29(10):1732-9. doi: 10.1016/j.peptides.2008.05.026.

Olofsson LE, Unger EK, Cheung CC, Xu AW. Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance. Proc Natl Acad Sci U S A. 2013 Feb;110(8):E697-706. doi: 10.1073/pnas.1218284110.

Adams LA, Feldstein A, Lindor KD, Angulo P. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology. 2004 Apr;39(4):909-14. doi: 10.1002/hep.20140.

Xiang Z, Chen YP, Ma KF, et al. The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review. BMC Gastroenterol. 2013 Sep 23;13:140. doi: 10.1186/1471-230X-13-140.

Zhuravleva LV, Krivonosova EM. Comparative characteristics of hepatoprotective drugs is the key for their rational use. Sucasna gastroenterologia. 2013;4(72):35-71. (in Russian).




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2018

 

   Seo анализ сайта